keyword
https://read.qxmd.com/read/38609702/diagnostic-magnetic-resonance-imaging-characteristics-of-congenital-mesoblastic-nephroma-a-retrospective-multi-center-international-society-of-pediatric-oncology-renal-tumor-study-group-siop-rtsg-radiology-panel-study
#1
JOURNAL ARTICLE
Justine N van der Beek, Jens-Peter Schenk, Carlo Morosi, Tom A Watson, Ana Coma, Norbert Graf, Tanzina Chowdhury, Gema L Ramírez-Villar, Filippo Spreafico, Nils Welter, Kristina Dzhuma, Harm van Tinteren, Ronald R de Krijger, Marry M van den Heuvel-Eibrink, Annemieke S Littooij
BACKGROUND: Congenital mesoblastic nephroma is the most common solid renal tumor in neonates. Therefore, patients <3 months of age are advised to undergo upfront nephrectomy, whereas invasive procedures at diagnosis in patients ≥3 months of age are discouraged by the International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG). Nevertheless, discriminating congenital mesoblastic nephroma, especially from the more common Wilms tumor, solely based on imaging remains difficult...
April 13, 2024: Pediatric Radiology
https://read.qxmd.com/read/38605554/anaplasia-in-wilms-tumor-a-critical-review
#2
REVIEW
Gordan M Vujanić, William Mifsud
Anaplasia in Wilms tumor is recognized as the most important prognostically unfavorable histological feature. It is subtyped as focal anaplastic Wilms tumor (FAWT) and diffuse anaplastic Wilms tumor (DAWT). Outcomes of patients with DAWT remain poor in patients with stage III and IV tumors. Important issues relevant to anaplasia in Wilms tumor, including prevalence, treatment, outcomes, biomarkers, anaplasia, and chemotherapy, and the concept of tumor aggressiveness, are reviewed and discussed here. We also consider the differences in clinical approaches to anaplasia in Wilms tumor between the two major renal tumor clinical research groups: the International Society of Paediatric Oncology (SIOP) Renal Tumour Study Group and the Children's Oncology Group (COG) Renal Tumor Group...
April 11, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38577638/case-report-autosomal-dominant-polycystic-kidney-disease-and-wilms-tumor-in-infancy-and-childhood
#3
Doviltyte Zina, Kiudeliene Rosita, Zviniene Kristina, Rutkauskiene Giedre, Masalskiene Jurate
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is rare but one of the most common inherited kidney diseases. Normal kidney function is maintained until adulthood in most patients. About 7 in 10 patients with ADPKD develop kidney failure in the latter half of their fifth decade of life. Wilms' tumor, or nephroblastoma, is the most common malignant tumor stemming from kidney cells in the pediatric age group. This type of tumor is the most frequently occurring kidney malignancy in children between the ages of 0 and 5 years...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38556746/international-society-of-paediatric-oncology-siop-global-mapping-programme-latin-american-society-of-pediatric-oncology-slaop-country-level-report
#4
JOURNAL ARTICLE
Andrea Cappellano, Maite Gorostegui, Oscar Gonzalez-Ramella, Nevicolino Pereira Carvalho Filho, Diana Valencia, Luisa Chantada, Claudia Sampor, María J Serrano, Carla Macedo, Oscar Ramirez, Susan Sardinas, Eva Lezcano, Patricia Calderón, Yessika Gamboa, Ligia Fu, Wendy Gómez, Magdalena Schelotto, Cecilia Ugaz, Pablo Lobos, Simone Dos Santos Aguiar, Katiuska Moreno, Julia Palma, Gissela Sánchez, Filomena Moschella, Pascale Yola Heurtelou Gassant, Thelma Velasquez, Karina Quintero, Florencia Moreno, Milena Villarroel, Soad Fuentes Alabi, Liliana Vasquez, Julia Challinor, Guillermo L Chantada
BACKGROUND: Latin American countries are improving childhood cancer care, showing strong commitment to implement the Global Initiative for Childhood Cancer, but there are scant publications of the situation at a continental level. METHODS: As part of the International Society of Paediatric Oncology Global Mapping project, delegates of each country participating in the Latin American Society of Pediatric Oncology (SLAOP) and chairs of national pediatric oncology societies and cooperative groups were invited to provide information regarding availability of national pediatric cancer control programs (NPCCP), pediatric oncology laws, pediatric oncology tumor registries, and training programs and support to diagnosis and treatment...
March 31, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38539574/correction-bailey-et-al-clinical-trials-in-high-risk-medulloblastoma-evolution-of-the-siop-europe-hr-mb-trial-cancers-2022-14-374
#5
Simon Bailey, Nicolas André, Lorenza Gandola, Maura Massimino, Keith Wheatley, Simon Gates, Victoria Homer, Stefan Rutkowski, Steven C Clifford
In the original publication [...].
March 7, 2024: Cancers
https://read.qxmd.com/read/38508973/correlation-of-ct-scan-response-to-necrosis-and-volume-changes-with-histopathology-in-children-with-wilms-tumor
#6
JOURNAL ARTICLE
Niaz Nilave, Sajida Nahid, Saiyeda Karim, Shahnoor Islam, Amirul Morshed
BACKGROUND: Wilms' tumor is the most common renal tumor in children. OBJECTIVE: To correlate the percentage of necrosis and tumor volume change found in preoperative Contrast Enhance Computed Tomography (CECT) scan of the abdomen with post-operative histopathological findings of Wilms Tumor (WT). METHODS: In this prospective study from January 2020 to December 2022, out of 33 patients, 15 patients with unilateral localized WT (stage I, II, and III) treated according to SIOP UMBRELLA protocol 2016 were included...
February 27, 2024: Journal of Pediatric Surgery
https://read.qxmd.com/read/38492671/estro-siope-guideline-clinical-management-of-radiotherapy-in-atypical-teratoid-rhabdoid-tumors-at-rts
#7
JOURNAL ARTICLE
Beate Timmermann, Claire Alapetite, Karin Dieckmann, Rolf-Dieter Kortmann, Yasmin Lassen-Ramshad, John H Maduro, Monica Ramos Albiac, Umberto Ricardi, Damien C Weber
BACKGROUND AND PURPOSE: Treatment of patients with atypical teratoid/rhabdoid (AT/RT) is challenging, especially when very young (below the age of three years). Radiotherapy (RT) is part of a complex trimodality therapy. The purpose of this guideline is to provide appropriate recommendations for RT in the clinical management of patients not enrolled in clinical trials. MATERIALS AND METHODS: Nine European experts were nominated to form a European Society for Radiotherapy and Oncology (ESTRO) guideline committee...
March 14, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38445717/surface-guided-radiotherapy-practice-in-paediatric-oncology-a-survey-on-behalf-of-the-siope-radiation-oncology-working-group
#8
JOURNAL ARTICLE
Enrica Seravalli, Petra S Kroon, Stephanie Bolle, Cathy Dunlea, Semi B Harrabi, Anne Laprie, Yasmin Lassen-Ramshad, Gillian Whitfield, Geert O Janssens
INTRODUCTION: Surface guided radiotherapy (SGRT) is increasingly being implemented to track patient's surface movement and position during radiation therapy. However, limited information is available on the SGRT use in paediatrics. The aim of this double survey was to map SIOPE (European Society for Paediatric Oncology) -affiliated centres using SGRT and to gain information on potential indications, observed or expected benefits. MATERIALS AND METHODS: A double online survey was distributed to 246 SIOPE-affiliated radiotherapy centres...
March 5, 2024: British Journal of Radiology
https://read.qxmd.com/read/38439802/the-role-of-international-society-of-paediatric-oncology-siop-in-advancing-global-childhood-cancer-care
#9
JOURNAL ARTICLE
Julia Challinor, Alan Davidson, Guillermo Chantada, Rejin Kebudi, Kathy Pritchard-Jones
The Société Internationale d'Oncologie Pédiatrique [International Society of Paediatric Oncology] (SIOP), founded in 1969, aims to improve the lives of children and adolescents with cancer through global collaboration, education, training, research and advocacy. The annual congress provides the opportunity to share late-breaking research, clinical experiences and debate, with experts worldwide. SIOP's six Continental Branches represent their constituent members in North America, Oceania, Latin America, Africa, Europe and Asia and bring best practices and recent research findings of value to their specific patient populations...
2024: Ecancermedicalscience
https://read.qxmd.com/read/38415234/grossing-to-reporting-of-wilms-tumor-with-emphasis-on-proper-sampling-in-treatment-naive-and-postchemotherapy-specimens-and-their-clinicopathological-correlation-with-outcome
#10
JOURNAL ARTICLE
Mohan Krishna Pasam, B Vishal Rao, Sai Kiran Chaganty, Rakesh Manilal Sharma, Veerendra Patil, Suseela Kodandapani, Sundaram Challa, Subramanyeshwar Rao Thammineedi
CONTEXT: Emphasis on grossing to reporting for the assessment of histopathological parameters predicting outcomes in Wilms tumor. AIMS: To analyze various clinicopathological parameters that effect outcomes in treatment naïve and post chemotherapy Wilms tumor specimens. SETTINGS AND DESIGN: This was a retrospective observational study. SUBJECTS AND METHODS: All patients diagnosed with Wilms tumor between 2012 and 2018 at our institute will be included with their clinical findings, laboratory reports, and radiological findings...
2024: Urology Annals
https://read.qxmd.com/read/38406888/paediatric-cbct-protocols-for-image-guided-radiotherapy-outcome-of-a-survey-across-siop-europe-affiliated-countries-and-literature-review
#11
JOURNAL ARTICLE
Daniella Elisabet Østergaard, Abigail Bryce-Atkinson, Mikkel Skaarup, Bob Smulders, Lucy Siew Chen Davies, Gillian Whitfield, Geert O Janssens, Lisa Lyngsie Hjalgrim, Ivan Vogelius Richter, Marcel van Herk, Marianne Aznar, Maja Vestmø Maraldo
BACKGROUND: Implementation of daily cone-beam CT (CBCT) into clinical practice in paediatric image-guided radiotherapy (IGRT) lags behind compared to adults. Surveys report wide variation in practice for paediatric IGRT and technical information remains unreported. In this study we report on technical settings from applied paediatric CBCT protocols and review the literature for paediatric CBCT protocols. METHODS: From September to October 2022, a survey was conducted among 246 SIOPE-affiliated centres across 35 countries...
January 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38376530/brain-stem-tumors-in-children-less-than-3%C3%A2-months-clinical-and-radiologic-findings-of-a-rare-disease
#12
JOURNAL ARTICLE
Danai Papangelopoulou, Brigitte Bison, Lars Behrens, Simon Bailey, Marc Ansari, Karoline Ehlert, Ofelia Cruz Martinez, Christof M Kramm, Andres Morales La Madrid, Andre O von Bueren
PURPOSE: Brain stem tumors in children < 3 months at diagnosis are extremely rare. Our aim is to study a retrospective cohort to improve the understanding of the disease course and guide patient management. METHODS: This is a multicenter retrospective analysis across the European Society for Pediatric Oncology SIOP-E HGG/DIPG Working Group linked centers, including patients with a brainstem tumor diagnosed between 2009 and 2020 and aged < 3 months at diagnosis...
February 20, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38319190/how-to-improve-initial-diagnostic-accuracy-of-kidney-tumours-in-childhood-a-non-invasive-approach
#13
JOURNAL ARTICLE
Nils Welter, Gregor Metternich, Rhoikos Furtwängler, Ahmed Bayoumi, Marvin Mergen, Leo Kager, Christian Vokuhl, Steven W Warmann, Jörg Fuchs, Clemens-Magnus Meier, Patrick Melchior, Manfred Gessler, Stefan Wagenpfeil, Jens-Peter Schenk, Norbert Graf
Non-invasive differentiation of paediatric kidney tumours is particularly important in the SIOP-RTSG protocols, which recommend pre-operative chemotherapy without histological confirmation. The identification of clinical and tumour-related parameters may enhance diagnostic accuracy. Age, metastases, and tumour volume (TV) were retrospectively analysed in 3306 patients enrolled in SIOP/GPOH 9, 93-01, and 2001 including Wilms tumour (WT), congenital mesoblastic nephroma (CMN), clear cell sarcoma (CCSK), malignant rhabdoid tumour of the kidney (MRTK), and renal cell carcinoma (RCC)...
February 6, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38291372/loggic-firefly-2-a-phase-3-randomized-trial-of-tovorafenib-vs-chemotherapy-in-pediatric-and-young-adult-patients-with-newly-diagnosed-low-grade-glioma-harboring-an-activating-raf-alteration
#14
RANDOMIZED CONTROLLED TRIAL
Cornelis M van Tilburg, Lindsay B Kilburn, Sébastien Perreault, Rene Schmidt, Amedeo A Azizi, Ofelia Cruz-Martínez, Michal Zápotocký, Katrin Scheinemann, Antoinette Y N Schouten-van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li-Pen Tsao, Samuel C Blackman, Peter Manley, Till Milde, Ruth Witt, David T W Jones, Darren Hargrave, Olaf Witt
BACKGROUND: Pediatric low-grade glioma (pLGG) is essentially a single pathway disease, with most tumors driven by genomic alterations affecting the mitogen-activated protein kinase/ERK (MAPK) pathway, predominantly KIAA1549::BRAF fusions and BRAF V600E mutations. This makes pLGG an ideal candidate for MAPK pathway-targeted treatments. The type I BRAF inhibitor, dabrafenib, in combination with the MEK inhibitor, trametinib, has been approved by the United States Food and Drug Administration for the systemic treatment of BRAF V600E-mutated pLGG...
January 30, 2024: BMC Cancer
https://read.qxmd.com/read/38259681/emergency-angioembolization-for-life-threatening-hemorrhage-in-wilms-tumor
#15
Areej Salim, Sajid Ali, Muhammad Ali Sheikh, Tariq Latif, Islah Ud Din
INTRODUCTION: Renal artery embolization has been used in a palliative fashion for symptomatic relief of hematuria or flank pain in unresectable renal cell carcinoma in adults. There is limited data on the use of embolization for actively bleeding and unresectable tumors in the oncological pediatric population. CASE DESCRIPTION: A previously healthy 5-year-old boy with no significant past medical or surgical history presented to the clinic with gradually worsening abdominal distension associated with occasional abdominal pain, gross hematuria, and lethargy for four months...
2024: Journal of cancer & allied specialties
https://read.qxmd.com/read/38220088/evaluating-clinical-safety-and-analytical-impact-of-subvisible-silicone-oil-particles-in-biopharmaceutical-products
#16
JOURNAL ARTICLE
Miguel Saggu, George M Bou-Assaf, Reinhard Bucher, Ivan L Budyak, Jakob Buecheler, Shawn Cao, Minna Groenning, Emon Khan, Stanley C Kwok, Shalini Minocha, Karthik Pisupati, Vinay Radhakrishnan, Nicoline Videbæk, Dennis T Yang, Bin Zhang, Linda O Narhi
Silicone oil is a commonly used lubricant in pre-filled syringes (PFSs) and can migrate over time into solution in the form of silicone oil particles (SiOPs). The presence of these SiOPs can result in elevated subvisible particle counts in PFS drug products compared to other drug presentations such as vials or cartridges. Their presence in products presents analytical challenges as they complicate quantitation and characterization of other types of subvisible particles in solution. Previous studies have suggested that they can potentially act as adjuvant resulting in potential safety risks for patients...
January 12, 2024: Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38185745/omission-of-adjuvant-chemotherapy-in-patients-with-completely-necrotic-wilms-tumor-stage-i-and-radiotherapy-in-stage-iii-the-30-year-siop-rtsg-experience
#17
JOURNAL ARTICLE
Gordan M Vujanić, Norbert Graf, Ellen D'Hooghe, Kathy Pritchard-Jones, Christophe Bergeron, Harm van Tinteren, Rhoikos Furtwängler
BACKGROUND: Completely necrotic Wilms tumor (CN-WT) following preoperative chemotherapy has been regarded as low-risk WT since the International Society of Paediatric Oncology (SIOP) 93-01 study, and patients have been treated with reduced postoperative therapy. The aim of the study was to evaluate whether the omission of adjuvant chemotherapy in patients with localized CN-WT stage I and radiotherapy in stage III was safe. PATIENTS AND METHODS: The retrospective observational study of outcomes of patients diagnosed with localized CN-WT on central pathology review and treated according to the SIOP 93-01 and SIOP-WT-2001 protocols (1993-2022)...
March 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38159681/the-organization-of-care-in-pediatric-radiotherapy-across-siop-europe-affiliated-centers-a-multicenter-survey-in-the-framework-of-the-joint-action-on-rare-cancers-project
#18
JOURNAL ARTICLE
Geert O Janssens, Beate Timmermann, Anne Laprie, Henry Mandeville, Laetitia Padovani, Cyrus Chargari, Pamela Kearns, Olga Kozhaeva, Leila Kameric, Anita Kienesberger, Peter S N van Rossum, Tom Boterberg, Yolande Lievens, Gilles Vassal
BACKGROUND/PURPOSE: To reduce inequalities among SIOPE-affiliated countries, standard and optional levels to deliver 'Good Clinical Practice' compliant treatment in pediatric radiation oncology have been published. The aim of this project was to map the availability of pediatric radiotherapy resources across SIOPE-affiliated radiotherapy departments. MATERIALS/METHODS: An online survey with 34 questions was distributed to 246 radiotherapy departments across 35 SIOPE-affiliated countries...
December 28, 2023: Radiotherapy and Oncology
https://read.qxmd.com/read/38054692/siop-pediatric-oncology-services-global-mapping-program-latin-american-data-collection
#19
JOURNAL ARTICLE
Luisa Chantada, Maite Gorostegui, Jennifer Lowe, Neil Ranasinghe, Lucas Villegas, Jennifer Geel, Scott Howard, Eric Bouffet, Guillermo Chantada, Julia Challinor, Andrea Cappellano
The International Society of Paediatric Oncology (SIOP) launched a program to map all pediatric cancer facilities around the world. After the results in Africa were completed, the strategy for data collection for Latin America was revised to improve the accuracy and avoid duplications. In partnership with SIOP, the Sociedad Latino Americana de Oncología Pediátrica (SLAOP) approached their delegates who provided the contacts for a 10-question survey about their institutional capacities. Data were collected by email, online meetings, or telephone calls, and stored in a secure platform...
December 6, 2023: Pediatric Blood & Cancer
https://read.qxmd.com/read/38035461/redo-nephron-sparing-surgery-in-stage-v-pediatric-renal-tumors-a-report-from-the-siop-gpoh-study-group-for-renal-tumors
#20
JOURNAL ARTICLE
Jörg Fuchs, Matthias C Schunn, Jürgen F Schäfer, Martin Ebinger, Norbert Graf, Rhoikos Furtwängler, Steven W Warmann
PURPOSE: Nephron-sparing Surgery (NSS) is the surgical treatment of choice in children with bilateral renal tumors or in syndromatic patients. With an increasing role of this surgical approach, there is also an increased number of tumor relapses after NSS. Aim of this study was to evaluate a second ("Redo-") NSS in children with relapsed renal tumors. MATERIALS AND METHODS: We retrospectively analysed patients undergoing Redo-NSS for relapsed kidney tumors between 2009 and 2021 at our institution, which represents a national reference center of the SIOP/GPOH renal tumor study group...
November 22, 2023: European Journal of Surgical Oncology
keyword
keyword
27879
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.